← Back to NEO

NEOGENOMICS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 28/07/2026Mar 2026Filed 28/07/2026Sep 2025Filed 28/10/2025Jun 2025Filed 28/07/2026Mar 2025Filed 28/07/2026Sep 2024Filed 28/10/2025Jun 2024Filed 28/10/2025Mar 2024Filed 28/10/2025
$202$187$188$181$168$168$165$156
$2.2−$17−$27−$45−$26−$18−$19−$27
131129128128127127126126

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.